Sorry, you need to enable JavaScript to visit this website.

GREENSTONE LLC INTRODUCES TOLTERODINE TARTRATE TABLETS
Authorized Generic of Detrol®

PEAPACK, N.J., January, 2014 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Tolterodine Tartrate Tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 1mg x 60; 1mg x500; 2mg x 60 and 2mg x500.

Greenstone’s Tolterodine Tartrate Tablets product is the authorized generic of, and equivalent to the innovator’s product, DETROL® (tolterodine tartrate tablets). Their new authorized generic adds to Greenstone’s consistently growing line of products and is backed by the power and scale of Pfizer’s
165-year worldwide reputation for a commitment to integrity, quality, and supply reliability. As a subsidiary of Pfizer, Greenstone operates under the same values and commitment to bring quality authorized generics to customers, payers, and the patients it serves.

See the Full Prescribing Information for Greenstone’s Tolterodine Tartrate Tablets at http://www.greenstonellc.com/product-list.aspx. For more information about Greenstone LLC and its products, visit http://greenstonellc.com.